John H. Sampson, M.D., Ph.D., M.H.Sc., M.B.A.
John H. Sampson, M.D., Ph.D., M.H.Sc., M.B.A.
Wilkins Distinguished Professor and Chief of Neurosurgery
Verified email at - Homepage
Cited by
Cited by
Bevacizumab plus irinotecan in recurrent glioblastoma multiforme
JJ Vredenburgh, A Desjardins, JE Herndon, J Marcello, DA Reardon, ...
Journal of clinical oncology 25 (30), 4722-4729, 2007
Phase II trial of gefitinib in recurrent glioblastoma
JN Rich, DA Reardon, T Peery, JM Dowell, JA Quinn, KL Penne, ...
Journal of Clinical Oncology 22 (1), 133-142, 2004
Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma
JH Sampson, AB Heimberger, GE Archer, KD Aldape, AH Friedman, ...
Journal of clinical oncology 28 (31), 4722, 2010
Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma
JH Sampson, JH Carter, AH Friedman, HF Seigler
Journal of neurosurgery 88 (1), 11-20, 1998
Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma
PE Fecci, DA Mitchell, JF Whitesides, W Xie, AH Friedman, GE Archer, ...
Cancer research 66 (6), 3294-3302, 2006
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
M Weller, N Butowski, DD Tran, LD Recht, M Lim, H Hirte, L Ashby, ...
The Lancet Oncology 18 (10), 1373-1385, 2017
Proteomic and immunologic analyses of brain tumor exosomes
MW Graner, O Alzate, AM Dechkovskaia, JD Keene, JH Sampson, ...
The FASEB Journal 23 (5), 1541-1557, 2009
Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma
S Kunwar, S Chang, M Westphal, M Vogelbaum, J Sampson, G Barnett, ...
Neuro-oncology 12 (8), 871-881, 2010
Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma
DA Mitchell, W Xie, R Schmittling, C Learn, A Friedman, RE McLendon, ...
Neuro-oncology 10 (1), 10-18, 2008
Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
H Okada, M Weller, R Huang, G Finocchiaro, MR Gilbert, W Wick, ...
The Lancet Oncology 16 (15), e534-e542, 2015
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
DA Mitchell, KA Batich, MD Gunn, MN Huang, L Sanchez-Perez, SK Nair, ...
Nature 519 (7543), 366-369, 2015
Phase II study of imatinib mesylate plus hydroxyurea in adults with recurrent glioblastoma multiforme
DA Reardon, MJ Egorin, JA Quinn, JN Rich, I Gururangan, ...
Journal of Clinical Oncology 23 (36), 9359-9368, 2005
Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion
A Lal, CA Glazer, HM Martinson, HS Friedman, GE Archer, JH Sampson, ...
Cancer research 62 (12), 3335-3339, 2002
Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group
S Kunwar, MD Prados, SM Chang, MS Berger, FF Lang, JM Piepmeier, ...
Journal of Clinical Oncology 25 (7), 837-844, 2007
Phase II Trial of Murine 131I-Labeled Antitenascin Monoclonal Antibody 81C6 Administered Into Surgically Created Resection Cavities of Patients With Newly …
DA Reardon, G Akabani, R Edward Coleman, AH Friedman, HS Friedman, ...
Journal of Clinical Oncology 20 (5), 1389-1397, 2002
Phase II trial of temozolomide in patients with progressive low-grade glioma
JA Quinn, DA Reardon, AH Friedman, JN Rich, JH Sampson, ...
Journal of clinical oncology 21 (4), 646-651, 2003
Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma
JH Sampson, KD Aldape, GE Archer, A Coan, A Desjardins, AH Friedman, ...
Neuro-oncology 13 (3), 324-333, 2011
Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-α and a mutated form of the …
JH Sampson, G Akabani, GE Archer, DD Bigner, MS Berger, AH Friedman, ...
Journal of neuro-oncology 65 (1), 27-35, 2003
An epidermal growth factor receptor variant III–targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme
JH Sampson, GE Archer, DA Mitchell, AB Heimberger, JE Herndon, ...
Molecular cancer therapeutics 8 (10), 2773-2779, 2009
Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma
JA Quinn, SX Jiang, DA Reardon, A Desjardins, JJ Vredenburgh, JN Rich, ...
Journal of Clinical Oncology 27 (8), 1262, 2009
The system can't perform the operation now. Try again later.
Articles 1–20